These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6177929)

  • 1. Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine.
    Hof RP; Hof A; Neumann P
    J Cardiovasc Pharmacol; 1982; 4(3):352-62. PubMed ID: 6177929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
    Hof RP
    Br J Pharmacol; 1984 May; 82(1):51-60. PubMed ID: 6733358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.
    Hof RP; Hof A
    Basic Res Cardiol; 1985; 80(1):66-75. PubMed ID: 3985926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.
    Hof RP
    Br J Pharmacol; 1985 May; 85(1):75-87. PubMed ID: 4027474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs.
    Hof RP; Hof A; Scholtysik G; Menninger K
    J Cardiovasc Pharmacol; 1984; 6(3):407-16. PubMed ID: 6202965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity.
    Hof RP
    Gen Pharmacol; 1985; 16(1):1-6. PubMed ID: 2579873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo.
    Hof RP; Scholtysik G
    J Cardiovasc Pharmacol; 1983; 5(2):176-83. PubMed ID: 6188886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
    Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the vasoconstrictor effects of noradrenaline and serotonin by the selective calcium antagonist PY 108-068 in the peripheral circulation of anesthetized cats.
    Hof RP; Hof A; Kalkman HO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S53-60. PubMed ID: 2414596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual inhibition and synergistic effects of ergotamine and the calcium antagonist darodipine.
    Hof RP; Hof A
    Gen Pharmacol; 1986; 17(3):309-14. PubMed ID: 3721185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
    Ohtsuka M; Ono T; Hiroi J; Esumi K; Kikuchi H; Kumada S
    J Cardiovasc Pharmacol; 1983; 5(6):1074-82. PubMed ID: 6196557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M; Nagura J; Kamei K; Fukuroda T
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats.
    Hof RP; Hof A
    J Cardiovasc Pharmacol; 1984; 6(1):68-75. PubMed ID: 6199614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
    Chibana T; Noguchi K; Ojiri Y; Sakanashi M
    Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic responses to nifedipine in dogs anesthetized with halothane.
    Tosone SR; Reves JG; Kissin I; Smith LR; Fournier SE
    Anesth Analg; 1983 Oct; 62(10):903-8. PubMed ID: 6614523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.
    Barthélémy G; Chatelain P; Manning A
    Arch Int Pharmacodyn Ther; 1994; 327(2):204-19. PubMed ID: 7979829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of nicardipine in anesthetized open-chest dogs in the absence and presence of beta-adrenergic receptor blockade: a comparison with nifedipine and verapamil.
    Bongrani S; Razzetti R; Schiantarelli P
    J Cardiovasc Pharmacol; 1985; 7(5):899-905. PubMed ID: 2413298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.